Clinical Trials
Study Title:
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Harriet Eldredge-Hindy, at eldredge@musc.edu.
Study Coordinator, Zachary Bargeloh, at bargeloh@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |